CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Hartgraves & the Adventure in Time! FORT WORTH, TX / ACCESS Newswire / October 19, 2025 / Author Pete Hartgraves is ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...

I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

I recently received a blast email from a classmate, friend, lawyer, father and former president of the Boston City Council, ...

Oral Presentation Title: Development of a PlaCCine DNA Technology for Safe, Effective and Durable Vaccines Presenting Author: Douglas V. Faller, M.D., Ph.D., Chief Medical Officer, IMUNON Date and ...

Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, ...